201 related articles for article (PubMed ID: 26026393)
1. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
[TBL] [Abstract][Full Text] [Related]
4. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
[TBL] [Abstract][Full Text] [Related]
5. Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality.
Hu Y; Ding M; Yuan C; Wu K; Smith-Warner SA; Hu FB; Chan AT; Meyerhardt JA; Ogino S; Fuchs CS; Giovannucci EL; Song M
Gastroenterology; 2018 Mar; 154(4):916-926.e9. PubMed ID: 29158191
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer.
Chong DQ; Mehta RS; Song M; Kedrin D; Meyerhardt JA; Ng K; Wu K; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
Cancer Prev Res (Phila); 2015 Dec; 8(12):1138-45. PubMed ID: 26382604
[TBL] [Abstract][Full Text] [Related]
7. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
[TBL] [Abstract][Full Text] [Related]
8. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
Ng K; Meyerhardt JA; Wu K; Feskanich D; Hollis BW; Giovannucci EL; Fuchs CS
J Clin Oncol; 2008 Jun; 26(18):2984-91. PubMed ID: 18565885
[TBL] [Abstract][Full Text] [Related]
9. Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer.
Eichelmann F; Schulze MB; Wittenbecher C; Menzel J; Weikert C; di Giuseppe R; Biemann R; Isermann B; Fritsche A; Boeing H; Aleksandrova K
JAMA Netw Open; 2019 Mar; 2(3):e190896. PubMed ID: 30901045
[TBL] [Abstract][Full Text] [Related]
10. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
[TBL] [Abstract][Full Text] [Related]
11. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
[TBL] [Abstract][Full Text] [Related]
12. Aspirin use and survival after diagnosis of colorectal cancer.
Chan AT; Ogino S; Fuchs CS
JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
[TBL] [Abstract][Full Text] [Related]
13. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
[TBL] [Abstract][Full Text] [Related]
14. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
15. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
[TBL] [Abstract][Full Text] [Related]
17. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients.
Boakye D; Jansen L; Schöttker B; Jansen EHJM; Schneider M; Halama N; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
Int J Cancer; 2020 Nov; 147(9):2373-2386. PubMed ID: 32319674
[TBL] [Abstract][Full Text] [Related]
18. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
[TBL] [Abstract][Full Text] [Related]
20. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
